SCHEMBL3767429

SCHEMBL3767429

N#CSCC(=O)c1cccc(Cl)c1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
HTT P42858 3/20 0.59
MAPT P10636 3/20 0.59
HPGD P15428 2/20 0.59
HSP90AA1 P07900 1/20 0.59
TSHR P16473 1/20 0.53
ERCC5 P28715 1/20 0.51
FEN1 P39748 1/20 0.51
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
MGAM O43451 1/20 0.41
AMY1A P0DUB6 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
P2RX7 Q99572 3/20 0.40
JAK2 O60674 1/20 0.38
ATM Q13315 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30377988 0.87 ALDH1A1 (0.62) ALDH1A1HTTMAPTHPGDHSP90AA1
SCHEMBL3761650 0.87 ALDH1A1 (0.62) ALDH1A1HTTMAPTHPGDHSP90AA1
SCHEMBL7380731 0.78 ERCC5 (0.56) ALDH1A1HTTMAPTTSHRERCC5
SCHEMBL11435010 0.74 ALDH1A1 (1.00) ALDH1A1HTTMAPTHPGDHSP90AA1
SCHEMBL3770989 0.74 ALDH1A1 (0.57) ALDH1A1HTTMAPTHPGDHSP90AA1
SCHEMBL3761126 0.74 HPGD (0.59) ALDH1A1HTTMAPTHPGDHSP90AA1
SCHEMBL3765579 0.73 ALDH1A1 (0.62) ALDH1A1HTTMAPTHPGDHSP90AA1
SCHEMBL3642633 0.73 ALDH1A1 (0.62) ALDH1A1HTTMAPTHPGDHSP90AA1
SCHEMBL3142115 0.73 ERCC5 (0.62) ALDH1A1TSHRERCC5FEN1TAS1R3
Acetonitrile SCHEMBL28214755 0.73 TSHR (0.78) ALDH1A1HTTMAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851473-B2 Amide compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-14 US disclosed
US-20080312226-A1 Amide Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-18 US disclosed
EP-1813606-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312226-A1 Amide Compound FAAH, FAAH2, CNR2 ALDH1A1 353/4885HTT 1945/4885MAPT 3805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.